Skip to main content
Image
Foto of MRONJ and Normal bone
Foto of MRONJ and Normal bone
Breadcrumb

Antiresorptive treatment and medication-related osteonecrosis of the jaw (MRONJ)

Research

Welcome to the next seminar within our seminar series on Biomaterials and Regenerative Medicine at the Department of Biomaterials, Sahlgrenska Academy at University of Gothenburg.

Lecture
Date
15 Apr 2021
Time
13:00 - 14:00
Location
Join via Zoom

Participants
Cecilia Larsson Wexell Assoc. Prof. Department of Biomaterials, Sahlgrenska academy, University of Gothenburg Consultant Oral & Maxillofacial Surgery, Skåne University Hospital, Lund
Good to know
Join via Zoom: https://gu-se.zoom.us/j/63410280562
Organizer
The Department of Biomaterials, Sahlgrenska Academy at University of Gothenburg

Abstract: 

The first major report on medication-related osteonecrosis of the jaw (MRONJ) related to antiresorptive therapy, e.g., treatment with bisphosphonates, was published in 2003. This is a rare, but serious side effect related to the treatment with bone-strengthening agents for cancer and osteoporosis patients. The indications for treatment with antiresorptive agents are increasing both for cancer patients and osteoporosis patients. In 2020, the Swedish medical products agency, Läkemedelsverket, updated the recommendations for osteoporosis treatment. Background and clinical experience of MRONJ will be presented.

For further information regarding the event, please contact:
Se contact card above - Furqan A. Shah